• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Acrivon Therapeutics, Inc. - Common Stock (NQ: ACRV )

    8.350 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Acrivon Therapeutics, Inc. - Common Stock

    < Previous 1 2 Next >
    ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q2 2024
    ACRV stock results show that Acrivon Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q1 2024
    ACRV stock results show that Acrivon Therapeutics beat analyst estimates for earnings per share the first quarter of 2024. 
    Via InvestorPlace
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
    Pre-market stock movers are a great way to start Thursday as we check out all of the hottest news moving shares this morning! 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Acrivon Therapeutics: Q4 Earnings Insights
    Via Benzinga
    Analyst Ratings for Acrivon Therapeutics
    Via Benzinga
    Recap: Acrivon Therapeutics Q3 Earnings
    Via Benzinga
    Analyst Expectations for Acrivon Therapeutics's Future
    Via Benzinga
    Crude Oil Down Over 1%; Cognyte Software Shares Plummet
    U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also... 
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Dow Dips 150 Points; Laser Photonics Shares Spike Higher
    U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,742.12 while the NASDAQ fell 0.16% to 16,227.77. The S&P... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Rail Vision (RVSN) Stock Up 17% Today?
    Rail Vision stock is taking off on Tuesday as RVSN investors celebrate an order for its AI Switch Yard System from a Class 1 company. 
    Via InvestorPlace
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    ACRV Stock Jumps 55% as Acrivon Therapeutics Gets $130 Million Boost
    Acrivon Therapeutics stock is up on Tuesday with heavy trading of ACRV shares alongside $130 million in new funding today. 
    Via InvestorPlace
    Acrivon Therapeutics Stock Is Soaring Tuesday: What's Going On?
    Acrivon Therapeutics has entered into a securities purchase agreement to issue and sell 8.235 million shares of its common stock at a price of $8.50 per share, as well as pre-funded warrants to... 
    Via Benzinga
    Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings
    U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 38,972.32 while the NASDAQ rose... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    ACRV Stock Earnings: Acrivon Therapeutics Misses EPS for Q4 2023
    ACRV stock results show that Acrivon Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results. 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023
    Via Benzinga
    7 Up-and-Coming Stocks to Buy for the Next Decade
    While less-established enterprises are best left for speculators, these up-and-coming stocks to buy also feature huge upside potential. 
    Via InvestorPlace
    Benzinga's Top Ratings Upgrades, Downgrades For June 2, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 8, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For April 20, 2023
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.